We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
226
Southern Company
SO
$109B
$1.75M 0.02%
36,379
-820
-2% -$41.8K
JJSF icon
227
J&J Snack Foods
JJSF
$1.43B
$1.75M 0.02%
11,510
+195
+2% +$27.4K
VFC icon
228
VF Corp
VFC
$5.63B
$1.74M 0.02%
25,026
-1,572
-6% -$104K
TYPE
229
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$1.73M 0.02%
71,785
+1,200
+2% +$28.1K
DD icon
230
DuPont de Nemours
DD
$18.5B
$1.73M 0.02%
9,578
-795
-8% -$143K
IEFA icon
231
iShares Core MSCI EAFE ETF
IEFA
$190B
$1.72M 0.02%
26,071
+8,415
+48% +$549K
REIS
232
DELISTED
Reis, Inc.
REIS
$1.71M 0.02%
83,020
+2,111
+3% +$40.8K
CRUS icon
233
Cirrus Logic
CRUS
$6.53B
$1.68M 0.02%
32,320
-8,748
-21% -$473K
SIX
234
DELISTED
Six Flags Entertainment Corp.
SIX
$1.66M 0.02%
24,917
+5,747
+30% +$368K
TECH icon
235
Bio-Techne
TECH
$11.2B
$1.6M 0.02%
49,320
+2,720
+6% +$86.4K
SCL icon
236
Stepan Co
SCL
$1.46B
$1.59M 0.02%
20,110
-95
-0.5% -$7.8K
MLAB icon
237
Mesa Laboratories
MLAB
$564M
$1.55M 0.02%
12,445
-100
-0.8% -$14K
OPLN
238
Openlane
OPLN
$4.21B
$1.51M 0.02%
+79,094
New +$1.46M
ZTS icon
239
Zoetis
ZTS
$32.4B
$1.51M 0.02%
20,951
+150
+0.7% +$10.3K
SEMG
240
DELISTED
SEMGROUP CORPORATION
SEMG
$1.51M 0.02%
49,921
+10,651
+27% +$281K
CHRW icon
241
C.H. Robinson
CHRW
$17.4B
$1.5M 0.02%
16,868
+12,068
+251% +$985K
CDK
242
DELISTED
CDK Global, Inc.
CDK
$1.49M 0.02%
20,940
+233
+1% +$15.6K
ZBH icon
243
Zimmer Biomet
ZBH
$18.2B
$1.44M 0.01%
12,322
– –
CVS icon
244
CVS Health
CVS
$133B
$1.42M 0.01%
19,538
+5,346
+38% +$389K
ATRI
245
DELISTED
Atrion Corp
ATRI
$1.41M 0.01%
2,235
+30
+1% +$19.6K
CSGS
246
DELISTED
CSG Systems International
CSGS
$1.41M 0.01%
32,070
+1,105
+4% +$47.7K
TWX
247
DELISTED
Time Warner Inc
TWX
$1.4M 0.01%
15,351
-10,718
-41% -$1.01M
AMZN icon
248
Amazon
AMZN
$2.92T
$1.4M 0.01%
23,900
+400
+2% +$22K
NATI
249
DELISTED
National Instruments Corp
NATI
$1.39M 0.01%
33,389
-15,785
-32% -$689K
DOX icon
250
Amdocs
DOX
$5.92B
$1.38M 0.01%
21,045
– –
8 9
10
11 12

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.